NCT05642975

Brief Summary

Most hip fractures occur in the elderly population. Opioid-related respiratory depression is more common in the elderly population but can cause severe brain damage or death. Reducing the amount of opioids administered before, during and after surgery by adding a regional block may increase the postoperative quality of recovery, reduce chronic pain syndromes, and may potentially facilitate the participation of patients in rehabilitation. Despite their potential advantages, peripheral nerve blocks are still not widely used in people with hip fractures. The primary objective of this study is to compare patients' postoperative pain scores and opioid consumption.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
66

participants targeted

Target at P25-P50 for not_applicable postoperative-pain

Timeline
Completed

Started Aug 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2022

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

November 30, 2022

Completed
8 days until next milestone

First Posted

Study publicly available on registry

December 8, 2022

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2023

Completed
Last Updated

August 26, 2024

Status Verified

August 1, 2024

Enrollment Period

9 months

First QC Date

November 30, 2022

Last Update Submit

August 21, 2024

Conditions

Keywords

Postoperative PainLumbar Erector Spinae Plane BlockFascia Iliaca Block

Outcome Measures

Primary Outcomes (1)

  • Opioid Consumption

    Comparing opioid consumption via Patient Controlled Analgesia (PCA) device

    48 hours

Secondary Outcomes (4)

  • Patient Satisfaction

    48 hours

  • Complications Related to Pain Management

    48 hours

  • Postoperative Pain Scores

    48 hours

  • The lengths of ICU and hospital stays

    7 days

Study Arms (3)

Suprainguinal Fascia Iliaca Block

ACTIVE COMPARATOR

The probe was placed over the inguinal ligament in close proximity to the anterior superior iliac spine and oriented in the parasagittal plane. It was then moved inferomedially along the line of the inguinal ligament to visualize the 'bow-tie' sign. After confirming the needle's position, a total volume of 30 ml of bupivacaine 0.25% was injected. Spinal anesthesia was administered to the patients in a lateral position using 2.5 ml of 0.5% heavy bupivacaine at the L3-L4 level.

Procedure: Regional Block Comparison

Erector Spinae Plane Block

ACTIVE COMPARATOR

The L5, L4, and L3 transverse processes and erector spinae muscles posteriorly were identified using ultrasound. The curved 6-2 MHz transducer was initially placed at the mid-vertebral line in the sagittal plane and then shifted laterally to visualize the erector spinae muscle and transverse process of the L3 vertebra. A total volume of 40 ml of bupivacaine 0.25% was injected. Spinal anesthesia was administered to the patients in a lateral position using 2.5 ml of 0.5% heavy bupivacaine at the L3-L4 level.

Procedure: Regional Block Comparison

Spinal Anesthesia Group (control)

ACTIVE COMPARATOR

Spinal anesthesia was administered to the patients in a lateral position using 2.5 ml of 0.5% heavy bupivacaine at the L3-L4 level.

Procedure: Regional Block Comparison

Interventions

Comparing postoperative pain and opioid consumption in groups

Erector Spinae Plane BlockSpinal Anesthesia Group (control)Suprainguinal Fascia Iliaca Block

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients over 18 years old, undergoing hip fracture surgery

You may not qualify if:

  • Patients with solid organ dysfunction, chronic opioid or corticosteroid use, bleeding diathesis, patients receiving inpatient medication, patients with psychiatric disorders and patients who cannot be contacted after surgery.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Marmara University Hospital

Istanbul, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Pain, PostoperativeFemoral Fractures

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and SymptomsFractures, BoneWounds and InjuriesLeg Injuries

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
SCREENING
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 30, 2022

First Posted

December 8, 2022

Study Start

August 1, 2022

Primary Completion

May 1, 2023

Study Completion

May 1, 2023

Last Updated

August 26, 2024

Record last verified: 2024-08

Locations